Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
ANI Pharmaceuticals Inc (ANIP)  
$67.25 0.14 (0.21%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 20,430,000
Market Cap: 1.37(B)
Last Volume: 2,387,520 Avg Vol: 2,380,888
52 Week Range: $38.04 - $69.69
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 320,801 421,551 1,262,027 1,480,093
Total Sell Value $21,062,080 $26,516,522 $74,515,877 $82,888,946
Total People Sold 9 9 12 12
Total Sell Transactions 28 40 87 90
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 719
  Page 6 of 29  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-22 4/A AS $51.38 $693,630 I/I (13,500) 1,292,620     -
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-22 4 AS $51.38 $693,630 D/D (13,500) 7,407     -
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-21 4/A AS $51.95 $615,244 I/I (11,843) 1,306,120     -
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-21 4 AS $51.95 $615,244 D/D (11,843) 20,907     -
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-20 4/A AS $51.93 $761,138 I/I (14,657) 1,317,963     -
   Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS   •       •      –    2023-06-20 4 AS $51.93 $761,138 D/D (14,657) 32,750     -
   Tannenbaum Renee P Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 20,211     -
   Nash David Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 38,561     -
   Thoma Jeanne Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 36,199     -
   Pera Antonio R Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 36,627     -
   Walsh Patrick D Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 70,302     -
   Haughey Thomas Director   –       •      –    2023-05-23 4 A $0.00 $0 D/D 6,865 47,116     -
   Carey Stephen P. SVP & CFO   •       –      –    2023-04-10 4 D $38.50 $174,559 D/D (4,534) 173,478     -
   Marken James G. SVP OPS & PROD DEV   •       –      –    2023-04-10 4 D $38.50 $88,127 D/D (2,289) 131,627     -
   Marken James G. SVP OPS & PROD DEV   •       –      –    2023-03-28 4 D $38.62 $20,237 D/D (524) 112,206     -
   Carey Stephen P. SVP AND CFO   •       –      –    2023-03-28 4 D $38.62 $54,840 D/D (1,420) 137,486     -
   Marken James G. SVP OPS & PROD DEV   •       –      –    2023-03-23 4 D $37.82 $92,735 D/D (2,452) 112,730     -
   Lalwani Nikhil PRESIDENT & CEO   •       •      –    2023-03-23 4 D $37.82 $660,148 D/D (17,455) 250,840     -
   Carey Stephen P. SVP AND CFO   •       –      –    2023-03-23 4 D $37.82 $159,752 D/D (4,224) 138,906     -
   Marken James G. SVP OPS & PROD DEV   •       –      –    2023-03-07 4 D $44.23 $108,806 D/D (2,460) 115,182     -
   Mutz Christopher HEAD OF RARE DISEASE   •       –      –    2023-03-07 4 D $44.23 $84,125 D/D (1,902) 37,660     -
   Carey Stephen P. SVP AND CFO   •       –      –    2023-03-07 4 D $44.23 $154,938 D/D (3,503) 143,130     -
   Lalwani Nikhil PRESIDENT & CEO   •       •      –    2023-03-07 4 D $44.23 $604,270 D/D (13,662) 268,295     -
   Gutwerg Ori SVP, GENERICS   •       –      –    2023-03-07 4 D $44.23 $103,587 D/D (2,342) 34,027     -
   Carey Stephen P. SVP & CFO   •       –      –    2023-02-28 4 A $0.00 $0 D/D 40,526 178,012     -
  719 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 29
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us